The Royal Women's Hospital Clinical Practice Guidelines (CPGs) are intended to provide guidance to health care professionals, based on a thorough evaluation of research evidence, on the practical assessment and management of specific clinical issues or situations. The guidelines allow some flexibility on the part of the health care professional based on the needs of the specific patient for whom they are caring.
|
|
Aim
|
The aim of the Neonatal Abstinence Syndrome (NAS) Clinical Practice Guideline (CPG) is to improve the identification and consistency of care of babies at risk of NAS. The document outlines antenatal care and assessments to identify babies at risk of NAS, care of babies at risk of NAS, treatment of NAS, and follow-up required for babies at risk of NAS.
|
CPG development process
|
The NAS CPG was developed by a multidisciplinary working group of paediatricians, midwives, pharmacist, counsellor, and managers from three tertiary health services (Mercy Hospital for Women, Southern Health and Royal Women’s Hospital). All working group members had expertise in services that provide care for babies at risk of NAS.
|
|
|
|
|
Reviewed: 6 September 2011
| First Published: 15 January 2008
|
|  | |
|
The Royal Women's Hospital Clinical Practice Guidelines (CPGs) are intended to provide guidance to health care professionals, based on a thorough evaluation of research evidence, on the practical assessment and management of specific clinical issues or situations. The guidelines allow some flexibility on the part of the health care professional based on the needs of the specific patient for whom they are caring.
|
Please remember to read our disclaimer.
|
